Literature DB >> 28359132

Point-of-Care Testing in Liver Disease and Liver Surgery.

Lasitha Abeysundara1, Susan V Mallett1, Ben Clevenger1.   

Abstract

The alterations in coagulation and hemostasis that accompany liver disease are complex, and while patients with this disease have traditionally been perceived as having a bleeding diathesis, it is now understood that in stable patients hemostasis is "re-balanced." Hepatic surgery, and particularly liver transplantation, can be associated with large fluid shifts, massive bleeding, and coagulopathy, as well as postoperative thrombosis. Point-of-care tests (POCTs) of coagulation facilitate goal-directed treatments and hemostatic monitoring in dynamic environments where the coagulation status can alter rapidly and often unpredictably. POCTs reflect more accurately the re-balanced hemostatic system than do conventional coagulation tests (CCTs). Viscoelastic POCT-guided transfusion algorithms permit a reduction in blood product administration and are a key component of patient blood management programs. Moreover, viscoelastic POCTs are better able to identify patients with hypercoagulability than CCTs. With thrombosis increasingly recognized to be a problem in patients with liver disease, POCTs hold promise for both individualized bleeding and thrombosis management. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2017        PMID: 28359132     DOI: 10.1055/s-0037-1599154

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  3 in total

1.  Diagnosis of acute serious illness: the role of point-of-care technologies.

Authors:  Gregory L Damhorst; Erika A Tyburski; Oliver Brand; Greg S Martin; Wilbur A Lam
Journal:  Curr Opin Biomed Eng       Date:  2019-09-16

2.  Whole blood thrombin generation profiles of patients with cirrhosis explored with a near patient assay.

Authors:  Jun Wan; Lara N Roberts; Wasiliki Hendrix; Joke Konings; Tsai-Wing Ow; Liane Rabinowich; Omar Barbouti; Bas de Laat; Roopen Arya; Vishal C Patel; Mark Roest; Ton Lisman; William Bernal
Journal:  J Thromb Haemost       Date:  2020-02-18       Impact factor: 5.824

3.  Thromboelastography-guided blood transfusion during cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: study protocol for a prospective randomised controlled trial.

Authors:  Shaoheng Wang; Qing Zhang; Linfeng Chen; Gang Liu; Peng Fei Liu
Journal:  BMJ Open       Date:  2020-11-12       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.